Doctor profile · Federal record
Dr. Danielle Farrior, ARNP
Family Nurse Practitioner (CMS: Nurse Practitioner) · Pensacola, FL
- NPI 1285931816
- Accepts Medicare
- MIPS 68.1 / 100 · 2023
- 16 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
8333 N Davis Hwy
Pensacola, FL 325146050
(850) 474-8386 - Mailing address
-
5645 Adelyn RD
Pensacola, FL 325048426
Credentials & registration
- NPI registered
- February 2011 — 15 yrs on file
- Year of graduation
- 2010 — 16 yrs since
- Specialty taxonomy
- 363LF0000X — NUCC code
- State license (1)
- Florida #ARNP9228640
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1285931816. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
7,217
Distinct HCPCS
10
Medicare allowed
$289,724
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 2,239 | 415 | $5 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 1,443 | 88 | $1 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 1,065 | 741 | $107 | |
17000 |
Destruction of precancer skin growth, 1 growth | 819 | 563 | $42 | |
17110 |
Destruction of skin growth, 1-14 growths | 407 | 339 | $91 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 371 | 249 | $75 | |
11102 |
Biopsy of related skin growth, first growth | 294 | 241 | $71 | |
96372 |
Injection of drug or substance under skin or into muscle | 204 | 90 | $11 | |
17262 |
Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 107 | 78 | $128 | |
11103 |
Biopsy of related skin growth, each additional growth | 94 | 56 | $42 |
In context: peer comparison
Among 69 peers in this city , average services per provider: 142. This provider delivers 51× the peer median.Open Payments
Industry payments received
All-time total
$1,980
Transactions
106
Manufacturers
13
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 35 | $563.54 | |
| Novartis Pharmaceuticals Corporation | 18 | $200.03 | |
| Janssen Biotech, Inc. | 9 | $186.96 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $160.67 | |
| Incyte Corporation | 8 | $154.93 | |
| GENZYME CORPORATION | 6 | $149.17 | |
| Regeneron Healthcare Solutions, Inc. | 6 | $134.82 | |
| UCB, Inc. | 4 | $116.24 | |
| E.R. Squibb & Sons, L.L.C. | 5 | $85.07 | |
| Mallinckrodt Hospital Products Inc. | 2 | $75.08 | |
| Lilly USA, LLC | 3 | $72.52 | |
| Arcutis Biotherapeutics, Inc. | 3 | $51.58 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $29.28 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
761
Patients
398
Total drug cost
$109,940
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ammonium Lactate | Generic | 313 | 151 | $17,173 |
| Ketoconazole | Generic | 131 | 66 | $3,059 |
| Fluconazole | Generic | 76 | 43 | $983 |
| Tretinoin | Generic | 37 | 13 | $3,924 |
| Clobetasol Propionate | Generic | 33 | 23 | $1,269 |
| Triamcinolone Acetonide | Generic | 32 | 27 | $191 |
| Doxycycline Hyclate | Generic | 25 | 15 | $1,164 |
| Hydrocortisone | Generic | 24 | 21 | $140 |
| Calcipotriene | Generic | 18 | 12 | $3,213 |
| Fluorouracil | Generic | 16 | 14 | $1,397 |
Frequently asked questions
What is Dr. Danielle Farrior's medical specialty?
Dr. Danielle Farrior practices Family Nurse Practitioner in Pensacola, FL.
Where does Dr. Danielle Farrior practice?
Dr. Danielle Farrior practices at 8333 N Davis Hwy, Pensacola, FL 325146050. Office phone: 8504748386.
What is Dr. Danielle Farrior's NPI?
Dr. Danielle Farrior's National Provider Identifier (NPI) is 1285931816, issued by NPPES.
Does Dr. Danielle Farrior accept Medicare assignment?
Yes. Dr. Danielle Farrior accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Danielle Farrior commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS J3301); Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.